Abstract-Although
H ypertension is the most powerful and modifiable risk factor for cardiovascular and cerebrovascular diseases. 1 However, different from the clinical use of the term hypertension, the actual relationship between blood pressure (BP) and the risk of vascular complications is continuous. [2] [3] [4] Down to a BP of 115/75 mm Hg, no definable threshold has been identified. 2, 3, 5 For this reason, the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure introduced prehypertension as a new subcategory of BP level in 2003. 2, 6 Prehypertension has been associated with cardiovascular disease, cerebrovascular disease, or even subclinical atherosclerosis [1] [2] [3] [4] [5] [7] [8] [9] [10] [11] ; however, the committee recommends only close follow-up or lifestyle modification for these patients. 5, 12 No consensus has been reached about the use of antihypertensive medication. 5, 10, 12 In this background, the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines introduced a novel definition of hypertension in their 2017 hypertension guidelines, including patients with a systolic BP (SBP) of 130 to 139 mm Hg or a diastolic BP (DBP) of 80 to 89 mm Hg in the stage 1 hypertension group. 13 This change could indicate that the committee emphasizes the importance of early and intensive management of the BP stratum for which only lifestyle change was previously recommended. However, an exact evaluation of how risky this novel stage 1 hypertension is for the development of vascular complications should first be performed.
Cerebral small vessel disease (cSVD) is a group of subclinical pathologies that increase the risk of stroke or dementia. 14, 15 Because stroke usually results in disabilities with limited neurological recoveries, early identification of a highrisk group, such as patients with cSVD lesions, and management of modifiable risk factors are important. 15 Hypertension is a potent risk factor for cSVD [16] [17] [18] ; however, whether this relationship is also true with the novel definition of hypertension is questionable. In this study, we aimed to evaluate the relationship between BP categories according to the 2017 ACC/AHA guidelines and cSVD, especially focusing on stage 1 hypertension.
Methods
Data supporting the findings of this study are available from the corresponding author on reasonable request.
Patients and Population
From a part of a consecutive registry of routine health checkups at a large center in Korea (Seoul National University Hospital Health Promotion Center) between January 2006 and December 2013, we included 2531 participants without the use of antihypertensive medication. We then excluded several participants according to the following exclusion criteria: (1) having a history of stroke or severe neurological deficit (n=41), (2) missing data on covariates (n=26), and (3) age <30 years (n=4). Finally, a total of 2460 neurologically healthy participants were included in the final analysis ( Figure S1 in the online-only Data Supplement). As parts of routine checkups, all participants underwent brain magnetic resonance imaging (MRI), brain magnetic resonance angiography, and laboratory examinations. The current study was approved by the Institutional Review Board at Seoul National University Hospital (Institutional Review Board No. 1502-026-647). Data supporting the findings of this study are available from the corresponding author on reasonable request.
Clinical Assessment
We evaluated demographic factors, clinical factors, and cardiovascular risk factors, including age, sex, body mass index, diabetes mellitus, hyperlipidemia, ischemic heart disease, current smoking, and use of antiplatelet medication. 19 Laboratory examinations were conducted after 12 hours of overnight fasting, including glucose profile, lipid profile, white blood cell counts, and hsCRP (high-sensitivity C-reactive protein) level. 19 BP was measured on the left arm by using sphygmomanometer with a cuff of appropriate size after the participants has rested on a chair for at least 5 minutes, following the standard protocol. 5 Two readings of SBP and DBP were taken at 5-minute intervals, and the average of each 2 readings was used as SBP and DBP data. As a main variable, we classified the participants' BP into 4 categories according to the 2017 ACC/AHA hypertension guidelines, as follows 13 : (1) 
Radiological Assessment
All participants in the current study underwent brain MRI with 1.5-or 3.0-Tesla MR scanners (Signa [GE Healthcare, Milwaukee, WI] or Magnetom Sonata [Siemens, Munich, Germany]). The basic slice thickness of the images was 5 mm in the axial plane, and we evaluated broad MRI acquisitions as follows: T1-weighted images, repetition time/echo time =500/11 ms; T2-weighted images, repetition time/echo time =5000/127 ms; T2-gradient echo images, repetition time/echo time =57/20 ms; and T2 fluid-attenuated inversion recovery images, repetition time/echo time =8800/127 ms.
In this study, we evaluated all 4 components of cSVD, including white matter hyperintensity (WMH), lacune of presumed vascular origin, cerebral microbleed (CMB), and enlarged perivascular space (EPVS). WMH volume was rated using a computer-assisted semiautomated method using Medical Imaging Processing, Analysis, and Visualization (MIPAV, version 7.3.0; National Institutes of Health; Bethesda, MD). 19 Lacunes were defined as asymptomatic welldefined 3 to 15 mm lesions with the same signal characteristics as cerebrospinal fluid on T2 or T1 MRI in the territory of perforating arterioles.
14 CMB was defined as a focal round lesion of <10 mm size with low signal on T2-gradient echo images. 14 Considering their different pathophysiologic mechanisms, we separately rated CMB lesions in lobar and deep areas. 17 We posited that deep CMB lesions have a closer relationship with stage 1 hypertension, as they are known to result from long-standing hypertensive injuries. 17 We defined EPVS as a round, oval, or linear lesion of <3 mm size with a signal similar to that of cerebrospinal fluid without a surrounding hyperintense rim.
14 EPVS in the basal ganglia level is known to be closely associated with other cSVDs. 20, 21 Thus, the number of EPVS lesions was measured in basal ganglia level. All radiological assessments were rated by a well-trained neurologist for data integrity (K.-W. Nam). Then, we the reproducibility of cSVD markers was calculated using 300 randomly assigned participants each for the intrarater and interrater (K.-W. Nam and H.-Y. Jeong) reliability coefficients (Table S1 ). Any disagreements were resolved through a discussion with a third rater (H.-M. Kwon).
Statistical Analysis
Continuous variables with a normal distribution are presented as mean±SD, whereas those with a non-normal distribution are presented as median (interquartile range). Continuous variables with skewed data were transformed into a log scale. Conversely, WMH volume was transformed into a square-root scale, because it had many zero values. To conduct univariate analysis, we used simple linear regression analyses for WMH volume and simple binary logistic regression analyses for lacunes, CMBs, and moderate-to-severe EPVS. Moderate-to-severe EPVS was defined as the presence of >10 EPVS lesions. Then, variables were included in the multivariable linear regression or binary logistic regression models, when they had P<0.10 in the univariate analysis or were considered clinically/theoretically significant (eg, sex). If multicollinearity was highly suspected, the Diabetes mellitus, n (%) 318 (13) Hyperlipidemia, n (%) 623 (25) Ischemic heart disease, n (%) 97 (4) Current smoking, n (%) 375 (15) Antiplatelet medication, n (%) 254 ( variable considered to be more clinically relevant was included in the multivariable regression model. 20, 21 Additional multivariable analyses for CMB lesions were conducted using the outcome variables lobar CMB and deep CMB, respectively, to confirm the hypothesis that these 2 types of CMB lesions have different pathophysiologies.
To compare the baseline characteristics of participants with different BP categories, we compared the demographic information and risk factor profiles across the BP categories. We used the KruskalWallis test and Jonkheere-Terpstra test for continuous variables, and the χ 2 test and linear-by-linear association analyses for categorical variables. All statistical analyses in the current study were performed using SPSS version 21.0 (IBM SPSS, Chicago, IL). Statistical significance was set at P<0.05.
Results
A total of 2460 healthy participants were assessed (mean age: 56 years; male sex: 54%; mean body mass index: 24.17 kg/ m 2 ). The median volume of WMH lesions was 1.10 (0.20-2.60) mL, and the prevalence of lacunes, CMBs, and moderate-to-severe EPVS was 179 (7%), 99 (4%), and 860 (35%), respectively. The participants were categorized according to the 2017 ACC/AHA guidelines, and the group distribution was as follows: (1) normal BP, 787 (32%); (2) elevated systolic BP, 329 (13%); stage 1 hypertension, 445 (18%); and (4) stage 2 hypertension, 899 (37%). The detailed baseline characteristics of the cohort are presented in Table 1 .
To identify the association between stage 1 hypertension and WMH volumes, we used multivariable linear regression analyses. In the analysis, stage 1 hypertension showed a close relationship with WMH volume (β=0.158; 95% CI, 0.046-0.269; P=0.006) after adjustment for confounders (Table 2) . Stage 2 hypertension presented a higher coefficient (β=0.267; 95% CI, 0.171-0.362) and a lower P value (P<0.001), showing a dose-response effect across the BP categories. Age (β=0.047; 95% CI, 0.043-0.052; P<0.001) and white blood cell counts (β=0.038; 95% CI, 0.015-0.062; P=0.002) were also significantly associated with WMH volumes, independent of the BP category ( Table 2) .
As other components of cSVD, lacunes, and moderateto-severe EPVS were also evaluated using the binary logistic regression analyses. (Table 4) . Age, male sex, body mass index, and diabetes mellitus were also related to moderate-to-severe EPVS, independent of the BP category.
There were 34 (1%) participants in the lobar CMB group and 76 (3%) participants in the deep CMB group. BP indicates blood pressure; hsCRP, high-sensitivity C-reactive protein; HTN, hypertension; IHD, ischemic heart disease; and WBC, white blood cell. *White matter hyperintensity volume was transformed into a squared-root scale. †P values were calculated after adjusting for age, sex, BP categories, diabetes mellitus, ischemic heart disease, current smoking, antiplatelet use, fasting glucose level, total cholesterol level, and white blood cell counts.
‡These variables were transformed into log scales.
Considering the small number of outcome variables and the possibility of overfitting, we conducted a backward stepwise regression analysis, which led to the same results (Table 6 ).
Discussion
In this study, we found that stage 1 hypertension as defined by the 2017 ACC/AHA guidelines was associated with a higher prevalence of cSVD compared with normal BP in a neurologically healthy population. Considering that these positive associations were prominent in the analyses of WMH, lacune, and deep CMB lesions, elevated BP seems to simultaneously have an important role in the development of diverse pathologies of cSVD.
To understand the close relationship between elevated BP and various pathologies of cSVD, several plausible explanations can be suggested. First, hyperplasia and hypertrophy of smooth muscle cells in arterial walls may play a major role. Elevated BP on the arterial wall induces smooth muscle cell proliferation and infiltration of blood-born cells into subendothelial areas. 1, 11, 22 In addition, various connective tissue materials accumulate, leading to focal intimal thickening of arteries. 22, 23 As these focal changes are highly sensitive, they could occur even after a brief period of BP elevation. 22, 23 This lipohyalinosis or arteriosclerosis could cause a diffuse hypoperfusion status or occlude small perforating arterioles, leading to cSVD lesions (eg, WMH and lacunes). 1, 19 Second, increased vascular stiffness should be considered. The medial layers of arteries have rich amounts of elastic fibers, which absorb pressures on the wall and attenuate damages to microvessels. 1, 11, 22 However, elastic fibers are vulnerable to tensile stress resulting from elevated BP. 11, 22 The degradation of elastic fibers and accumulation of cellular/connective tissue components make arteries stiffer. 11, 22, 24 Stiff vessels can lead to ischemic insult by directly propagating decreased perfusion or increased pulse pressure, leading to the development of WMH, lacunes, and deep CMBs, as confirmed in the present study. 1, 11, 25 Last, the close association between stage 1 hypertension and cSVD could result from their shared risk factors. Prehypertension, which was defined as stage 1 hypertension in this study, is already known to have an association with various cardiovascular risk factors. 4, 5, 26, 27 Thus, as Table S2 shows, patients with stage 1 hypertension may have a predisposition to cSVD development. BP indicates blood pressure; hsCRP, high-sensitivity C-reactive protein; HTN, hypertension; IHD, ischemic heart disease; OR, odds ratio; and WBC, white blood cell.
*P values were calculated after adjusting for age, sex, BP categories, diabetes mellitus, current smoking, antiplatelet use, total cholesterol level, and hsCRP level.
†These variables were transformed into log scales. BP indicates blood pressure; hsCRP, high-sensitivity C-reactive protein; HTN, hypertension; IHD, ischemic heart disease; OR, odds ratio; and WBC, white blood cell.
*P values were calculated after adjusting for age, sex, body mass index, BP categories, diabetes mellitus, hyperlipidemia, ischemic heart disease, current smoking, antiplatelet use, fasting glucose level, white blood cell counts, and hsCRP level.
†These variables were transformed into log scales.
Nevertheless, stage 1 hypertension did not show statistical significance in the development of moderate-to-severe EPVS, whereas a higher BP level (ie, stage 2 hypertension) seemed to have a role in the pathomechanism of that. Endothelial dysfunction is considered as a mechanism. Previous experimental studies have shown that elevated BP modifies the transport process of the endothelium via both transcellular and intercellular pathways, and these nondenuding changes depend on tangential or shear stress on the wall. 22 On the contrary, increased oxidative stress or inflammatory materials, which are commonly found in patients with hypertension, could also directly injure the vascular endothelium. 1, 26, 28, 29 Through destructive or nondestructive methods, impaired endothelium allows the perivascular infiltration of toxic materials into neural tissues or blockage of clearance via the glymphatic pathway, leading to the development of lobar CMB and EPVS. 30, 31 However, considering the weak association between stage 1 hypertension and EPVS or lobar CMB, strong and long-standing BP elevation may be required to evoke these changes. cSVD lesions act as potent risk factors of both stroke and dementia, which have been dramatically increasing incidence over the last decades and are becoming worldwide medical problems. Although a cross-sectional study do not have much power to change the BP treatment guidelines, our findings support the concept that early clinical intervention based on a new, stricter definition of stage 1 hypertension might lead to a meaningful prevention or delay of the development of both diseases, with decreased burden both for the individual patient and the society.
The current study has several limitations. First, this study was designed as a single-center retrospective study; thus, there is a possibility of selection bias. However, because we included a large number of participants and broadly examined the clinical and radiological factors, our cohort may be sufficient to give meaning to our findings. Second, owing to the limitation of being a cross-sectional study, we proved only the association but not the causality. Third, the prevalence of cSVD lesions, especially lacune and CMB, was relatively small. This may be attributable to the traits of our registry cohort, which included younger participants with a small burden of vascular risk factors. However, this BP indicates blood pressure; hsCRP, high-sensitivity C-reactive protein; HTN, hypertension; IHD, ischemic heart disease; OR, odds ratio; and WBC, white blood cell.
*P values were calculated after adjusting for age, sex, BP categories, current smoking, and antiplatelet use. †These variables were transformed into log scales. relatively healthy population allowed us to clearly assess the independent associations between novel stage 1 hypertension and lacune. Fourth, we used mixed modalities of 1.5-and 3.0-T MRI. Because the prevalence of cSVD was not significantly different between the 2 groups, our main results would remain the same. However, the bias arising from the different MRI qualities should also be taken into consideration. Last, because we used data from a health checkup registry, we used single-day measurements as baseline BP data. This could have caused the problem of misclassification of BP categories. However, previous epidemiological studies confirmed that BP measurements taken on a single day are also adequate for analysis. 32 Thus, our main results may be within the acceptable ranges.
Perspectives
Our study supports the association between novel stage 1 hypertension and a higher prevalence of cSVDs. These relationships were more prominent in WMH, lacune, and deep CMBs which were already known as having a significant correlation with elevated BP. Because cSVDs are wellknown risk factors for symptomatic stroke or dementia, our findings would indicate that new, stricter BP guidelines are plausible in terms of preventing diverse cSVDs before symptomatic events.
Conclusions
We demonstrated that the stage 1 hypertension, as defined by the 2017 ACC/AHA guidelines, is independently associated with the development of cSVD, especially WMHs, lacunes, and deep CMBs in a neurologically healthy population. Our findings seem to indicate that these new, stricter BP guidelines are plausible in terms of cSVD development. However, further large prospective studies are needed to confirm these findings.
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